Published in Gene Therapy Weekly, June 27th, 2002
Dr. Yupin Charoenvit of NMRC presented the data at the Experimental Biology 2002 meeting in New Orleans, Louisiana. This same peptide, called derG, has also induced protective effects in two other totally different and unrelated animal challenge models for herpes simplex virus and cancer.
The peptide appears to increase the animal's ability to fight off all of these three diseases. The peptide is a modified version of a human sequence known to bind to both human and mouse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.